MONTREAL, Aug. 31,
2023 /CNW/ - Carebook Technologies Inc.
("Carebook" or the "Company") (TSXV: CRBK) (OTCPK:
CRBKF) (XFRA: PMM1), a leading Canadian provider of innovative
digital health solutions, announces that an aggregate of 8,800,000
stock options were granted to employees, consultants and directors
of Carebook as part of their overall compensation and retention
program. 7,350,000 of these stock options were granted to directors
and officers of the Company. Each stock option entitles the holder
thereof to purchase one common share in the capital of the Company
(a "Common Share") at an exercise price of $0.10 per Common Share and expires on
August 25, 2033. All the stock
options will vest in three equal installments beginning on either
January 1, 2024 or January 1, 2025.
Following these grants, the Company has a total of
11,821,348 stock options outstanding (and 2,174,076 Common
Shares remain available for future issuance under the Company's
stock option plan).
About Carebook Technologies
Carebook's digital health
platform empowers its clients and more than 3.5 million members to
take control of their health journey. During 2021, the Company
completed the acquisitions of InfoTech Inc. ("InfoTech"), a
global leader in health and productivity risk management, and
CoreHealth Technologies Inc. ("CoreHealth"), owner of an
industry-leading wellness platform. In combination, these companies
create a comprehensive digital health platform that includes both
assessment tools and the technology to deliver complementary
solutions. Carebook's shares trade on the TSXV under the symbol
"CRBK," on the OTC Markets under the symbol "CRBKF," and are listed
on the Open Market of the Frankfurt Stock Exchange under the symbol
"PMM1."
www.carebook.com
For further information contact:
Carebook Investor Relations Contact:
Olivier Giner, CFO
Email : ir@carebook.com
Telephone: (450) 977-0709
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
Notice regarding forward-looking statements:
This release includes forward-looking information and
forward-looking statements within the meaning of Canadian
securities laws regarding Carebook, its subsidiaries and their
business. Often, but not always, forward-looking information can be
identified by the use of words such as "plans", "is expected",
"expects", "scheduled", "intends", "contemplates", "anticipates",
"believes", "proposes" or variations (including negative
variations) of such words and phrases, or state that certain
actions, events or results "may", "could", "would", "might" or
"will" be taken, occur or be achieved. Forward-looking information
in this release include statements with respect to revenue, our
2023 full year outlook, the Company's growth strategy, management's
expectations regarding revenue growth and cost management, contract
generation and the overall value of recently signed contracts, the
Company's path to profitability, the Company's M&A strategy and
the expected benefits from completed and integrated acquisitions.
Such statements are based on the current expectations of the
management of Carebook and are based on assumptions and subject to
risks and uncertainties. Although the management of Carebook
believes that the assumptions underlying these statements are
reasonable, they may prove to be incorrect, and undue reliance
should not be placed on such forward-looking statements. The
forward-looking statements reflect the Company's current views with
respect to future events based on currently available information
and are inherently subject to risks and uncertainties. The
forward-looking events and circumstances discussed in this release
may not occur by certain specified dates or at all and could differ
materially as a result of known and unknown risk factors and
uncertainties affecting the Company, including economic factors,
management's ability to manage and to operate the business of
Carebook, management's ability to identify attractive M&A
opportunities, management's ability to successfully integrate the
Company's completed acquisitions and to realize the synergies of
such acquisitions, management's ability to successfully complete
product studies, the equity markets generally and risks associated
with growth and competition, management's ability to achieve
profitability for the Company, as well as the risk factors
identified in the Company's management's discussion and analysis
for the year ended December 31,
2022, a copy of which can be found on SEDAR under the
Company's profile at www.sedar.com. Although Carebook has
attempted to identify important factors that could cause actual
actions, events or results to differ materially from those
described in forward-looking statements, there may be other factors
that cause actions, events or results to differ from those
anticipated, estimated or intended. Accordingly, readers should not
place undue reliance on any forward-looking statements or
information. No forward-looking statement can be guaranteed. Except
as required by applicable securities laws, forward-looking
statements speak only as of the date on which they are made and
Carebook does not undertake any obligation to publicly update or
revise any forward-looking statement, whether as a result of new
information, future events, or otherwise.
SOURCE Carebook Technologies Inc.